These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2173891)

  • 1. Leukotriene B4 in atopic dermatitis: increased skin levels and altered sensitivity of peripheral blood T-cells.
    Thorsen S; Fogh K; Broby-Johansen U; Søndergaard J
    Allergy; 1990 Aug; 45(6):457-63. PubMed ID: 2173891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    Ruzicka T; Simmet T; Peskar BA; Ring J
    J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.
    Fogh K; Herlin T; Kragballe K
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):450-5. PubMed ID: 2537352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
    Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
    Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children.
    Montuschi P; Martello S; Felli M; Mondino C; Barnes PJ; Chiarotti M
    Respir Res; 2005 Oct; 6(1):119. PubMed ID: 16236169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
    Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
    J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotrienes in atopic eczema.
    Ruzicka T
    Acta Derm Venereol Suppl (Stockh); 1989; 144():48-9. PubMed ID: 2552723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4.
    Payan DG; Missirian-Bastian A; Goetzl EJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3501-5. PubMed ID: 6328519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced neutrophil LTB4 release in atopic dermatitis patients despite normal fatty acid composition.
    Schäfer L; Kragballe K; Jepsen LV; Iversen L
    J Invest Dermatol; 1991 Jan; 96(1):16-9. PubMed ID: 1846166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; leukotriene B4 induces an OKT8(+), radiosensitive suppressor cell from resting, human OKT8(-) T cells.
    Atluru D; Goodwin JS
    J Clin Invest; 1984 Oct; 74(4):1444-50. PubMed ID: 6090503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators in normal, sensitive and diseased skin types.
    Reilly DM; Parslew R; Sharpe GR; Powell S; Green MR
    Acta Derm Venereol; 2000 May; 80(3):171-4. PubMed ID: 10954205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of leukotriene B4 in vitro and in vivo by radioimmunoassay.
    Salmon JA
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():25-8. PubMed ID: 3004135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods.
    Poubelle PE; Borgeat P; Rola-Pleszczynski M
    J Immunol; 1987 Aug; 139(4):1273-7. PubMed ID: 3039000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis.
    Koro O; Furutani K; Hide M; Yamada S; Yamamoto S
    J Allergy Clin Immunol; 1999 Apr; 103(4):663-70. PubMed ID: 10200017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of leukotriene B4 by a unique subset of human T-lymphocytes.
    Payan DG; Goetzl EJ
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):403-6. PubMed ID: 6206107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
    Reinhold U; Wehrmann W; Bauer R; Kreysel HW
    Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production.
    Yoshida S; Yasutomo K; Watanabe T
    J Med Invest; 2016; 63(3-4):187-91. PubMed ID: 27644556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions.
    Rola-Pleszczynski M
    J Immunol; 1985 Aug; 135(2):1357-60. PubMed ID: 2861228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil mediator release in atopic dermatitis.
    Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
    J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis.
    Yoshino T; Asada H; Sano S; Nakamura T; Itami S; Tamura M; Yoshikawa K
    J Invest Dermatol; 2000 Feb; 114(2):281-8. PubMed ID: 10651987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.